$CLOV insider trading
Over the last 12 months, Clover Health Investments insiders reported no purchases and 32 sales totaling $6.2M across SEC Form 4 filings. 94% of those filings were made under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- — 0 events
- Sold · 12m
- $6.2M 32 events
- Events · 12m
- 32 Form 4 filings, grouped
- Insiders · 12m
- 7 distinct reporters
- 10b5-1 share
- 94% of events, not dollars
All insider trades
Scroll the table sideways for price, value and marks.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | OLDAKOWSKI JOSEPH FRANKVP OF FINANCE AND CONTROLLER · O | ▼ Sale | 3,170 | $4.64 | $15K | -1.1% | plan |
| Sep 15, 2026 | Wai ConradCEO, Counterpart Health · O | ▼ Sale | 300,000 | $4.72 | $1.4M | -20.4% | plan · indirect |
| Sep 15, 2026 | Soares KarenChief Legal Officer · O | ▼ Sale | 6,846 | $4.78 | $33K | -0.4% | plan |
| Sep 15, 2026 | Reynoso Jamie L.CEO, Medicare Advantage · O | ▼ Sale | 9,273 | $4.78 | $44K | -0.3% | plan |
| Sep 14, 2026 | OLDAKOWSKI JOSEPH FRANKVP OF FINANCE AND CONTROLLER · O | ▼ Sale | 20,000 | $5.16 | $103K | -6.7% | — |
| Aug 17, 2026 | THORNTON JOSEPH CLAYInterim CFO · O | ▼ Sale | 17,775 | $4.39 | $78K | -1.4% | plan |
| Aug 10, 2026 | Toy AndrewChief Executive Officer · O·D | ▼ Sale | 87,798 | $4.65 | $408K | -0.9% | plan |
| Jul 20, 2026 | Soares KarenChief Legal Officer · O | ▼ Sale | 51,700 | $4.51 | $233K | -3.3% | plan |
| Jul 17, 2026 | Reynoso Jamie L.CEO, Medicare Advantage · O | ▼ Sale | 4,839 | $4.53 | $22K | -0.2% | plan |
| Jul 15, 2026 | Soares KarenChief Legal Officer · O | ▼ Sale | 10,519 | $4.67 | $49K | -0.7% | plan |
| Jul 15, 2026 | THORNTON JOSEPH CLAYInterim CFO · O | ▼ Sale | 4,630 | $4.67 | $22K | -0.4% | plan |
| Jul 15, 2026 | Toy AndrewChief Executive Officer · O·D | ▼ Sale | 62,711 | $4.67 | $293K | -0.7% | plan |
| Jul 15, 2026 | Wai ConradCEO, Counterpart Health · O | ▼ Sale | 24,215 | $4.67 | $113K | -2.1% | plan |
| Jul 15, 2026 | Reynoso Jamie L.CEO, Medicare Advantage · O | ▼ Sale | 13,119 | $4.67 | $61K | -0.5% | plan |
| Jul 8, 2026 | Reynoso Jamie L.CEO, Medicare Advantage · O | ▼ Sale | 2,384 | $4.68 | $11K | -0.1% | plan |
| Jul 6, 2026 | Reynoso Jamie L.CEO, Medicare Advantage · O | ▼ Sale | 6,229 | $5.26 | $33K | -0.2% | plan |
| Jul 1, 2026 | Toy AndrewChief Executive Officer · O·D | ▼ Sale | 313,476 | $5.32 | $1.7M | -3.2% | plan |
| Jun 17, 2026 | Reynoso Jamie L.CEO, Medicare Advantage · O | ▼ Sale | 2,360 | $4.78 | $11K | -0.1% | plan |
| Jun 16, 2026 | OLDAKOWSKI JOSEPH FRANKVP OF FINANCE AND CONTROLLER · O | ▼ Sale | 12,102 | $4.86 | $59K | -3.9% | plan |
| Jun 15, 2026 | Soares KarenChief Legal Officer · O | ▼ Sale | 4,681 | $4.61 | $22K | -0.3% | plan |
| Jun 15, 2026 | Reynoso Jamie L.CEO, Medicare Advantage · O | ▼ Sale | 6,350 | $4.61 | $29K | -0.2% | plan |
| Jun 11, 2026 | Reynoso Jamie L.CEO, Medicare Advantage · O | ▼ Sale | 7,289 | $4.91 | $36K | -0.3% | plan |
| May 28, 2026 | Wai ConradCEO, Counterpart Health · O | ▼ Sale | 220,426 | $3.99 | $879K | -13.7% | plan · indirect |
| Mar 18, 2026 | Reynoso Jamie L.CEO, Medicare Advantage · O | ▼ Sale | 5,833 | $1.91 | $11K | -0.2% | plan |
| Mar 4, 2026 | Priest Brady PatrickCEO of Home Care · O | ▼ Sale | 175,000 | $2.17 | $380K | -8.1% | — |
| Jan 20, 2026 | Reynoso Jamie L.CEO, Medicare Advantage · O | ▼ Sale | 4,597 | $2.58 | $12K | -0.2% | plan |
| Jan 7, 2026 | Reynoso Jamie L.CEO, Medicare Advantage · O | ▼ Sale | 2,102 | $2.53 | $5K | -0.1% | plan |
| Dec 18, 2025 | Reynoso Jamie L.CEO, Medicare Advantage · O | ▼ Sale | 4,913 | $2.61 | $13K | -0.2% | plan |
| Nov 4, 2025 | Reynoso Jamie L.CEO, Medicare Advantage · O | ▼ Sale | 30,385 | $3.58 | $109K | -1.1% | plan |
| Oct 17, 2025 | Reynoso Jamie L.CEO, Medicare Advantage · O | ▼ Sale | 16,514 | $2.69 | $44K | -0.6% | plan |
| Oct 7, 2025 | Reynoso Jamie L.CEO, Medicare Advantage · O | ▼ Sale | 2,012 | $2.65 | $5K | -0.1% | plan |
| Sep 17, 2025 | Reynoso Jamie L.CEO, Medicare Advantage · O | ▼ Sale | 4,914 | $3.09 | $15K | -0.2% | plan |
| Aug 13, 2025 | Loengard Anna UD | ▲ Buy | 26,500 | $2.59 | $69K | +852.1% | 2 tranches · indirect |
Every $CLOV filing on this page is one API call away
The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? Clover Health Investments filings can reach your inbox instead.
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $CLOV feed.